USA - NASDAQ:HLTH - US2297901009 - Common Stock
ChartMill assigns a Buy % Consensus number of 43% to HLTH. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-03-14 | BTIG | Downgrade | Buy -> Neutral |
| 2023-11-10 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2023-06-05 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2023-06-02 | Goldman Sachs | Downgrade | Buy -> Neutral |
| 2023-05-15 | BTIG | Maintains | Buy |
| 2023-05-01 | Goldman Sachs | Maintains | Buy |
| 2022-11-14 | Cowen & Co. | Maintains | Outperform |
| 2022-10-21 | Goldman Sachs | Maintains | Buy |
| 2022-08-11 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-05-12 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-10-19 | Cowen & Co. | Initiate | Outperform |
| 2021-10-19 | Goldman Sachs | Initiate | Buy |
| 2021-10-19 | Morgan Stanley | Initiate | Equal-Weight |
6 analysts have analysed HLTH and the average price target is 0.51 USD. This implies a price increase of 1075.12% is expected in the next year compared to the current price of 0.0434.
The consensus rating for CUE HEALTH INC (HLTH) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
The number of analysts covering CUE HEALTH INC (HLTH) is 6.